Profile data is unavailable for this security.
About the company
Tissue Regenix Group plc is a medical device company in regenerative medicine. The principal activity of the Company is the exploitation of platform technologies in the field of bone graft substitutes and soft tissue. It is focused on the development of regenerative products utilizing its two platform technologies, dCELL, addressing soft tissue needs, and BioRinse, providing sterile bone allografts. Its divisions include dCELL, BioRinse and GBM-V. The Company's patented decellularization technology (dCELL) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient's body that can be used to repair diseased or damaged body structures. Its proprietary BioRinse technology platform is primarily utilized to provide sterile tissue prepared in a manner to minimize the negative effects of processing. GBM-V produces tissue preparations for ophthalmology, primarily cornea, using conventional, classical methods.
- Revenue in GBP (TTM)23.78m
- Net income in GBP-823.31k
- Incorporated2006
- Employees76.00
- LocationTissue Regenix Group PLCUnit 3Phoenix Court, Lotherton Way, GarforthLEEDS LS25 2GYUnited KingdomGBR
- Phone+44 190 456 7609
- Fax+44 190 438 0517
- Websitehttps://www.tissueregenix.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MeVis Medical Solutions AG | 14.73m | 4.80m | 34.63m | 111.00 | 7.34 | 2.37 | 7.08 | 2.35 | 3.16 | 3.16 | 9.69 | 9.79 | 0.7128 | -- | 7.95 | 174,693.80 | 23.24 | 22.74 | 28.00 | 29.85 | 97.24 | 96.90 | 32.60 | 35.45 | -- | -- | 0.00 | 27.86 | -7.57 | -0.4922 | -36.84 | -8.38 | -17.46 | 0.00 |
| ANGLE plc | 2.19m | -20.13m | 35.50m | 150.00 | -- | 0.9387 | -- | 16.24 | -0.0772 | -0.0772 | 0.0084 | 0.0879 | 0.0539 | 0.3521 | 1.21 | 14,573.33 | -49.68 | -- | -56.03 | -- | 69.90 | -- | -920.95 | -- | 4.95 | -- | 0.1656 | -- | 109.99 | -- | 7.17 | -- | -- | -- |
| BrainCool AB (publ) | 2.39m | -4.24m | 36.24m | 20.00 | -- | 2.98 | -- | 15.17 | -0.2685 | -0.2685 | 0.1501 | 0.6527 | 0.2253 | 2.04 | 2.85 | 1,343,042.00 | -39.96 | -47.14 | -44.79 | -70.16 | -37.24 | -149.77 | -177.38 | -391.45 | 4.16 | -6.19 | 0.00 | -- | 32.06 | 78.35 | -34.34 | -- | -11.63 | -- |
| SyntheticMR AB (publ) | 6.04m | 349.92k | 36.42m | 43.00 | 115.52 | 4.82 | 43.31 | 6.03 | 0.1134 | 0.1134 | 1.96 | 2.72 | 0.6049 | -- | 1.53 | 2,203,514.00 | 3.50 | 7.19 | 4.24 | 8.85 | 70.27 | 69.70 | 5.79 | 9.08 | -- | 18.00 | 0.0066 | 21.50 | 30.67 | 13.05 | 70.34 | -7.33 | 27.30 | -- |
| Substrate Artificial Inteligence SA | 7.19m | -7.29m | 36.45m | 17.00 | -- | 0.324 | -- | 5.07 | -0.2986 | -0.2986 | 0.2718 | 0.3222 | 0.2526 | -4.40 | 3.31 | 506,400.00 | -24.84 | -- | -32.78 | -- | 127.29 | -- | -98.33 | -- | 0.7159 | -6.08 | 0.2089 | -- | 174.53 | -- | 42.10 | -- | -- | -- |
| Svas Biosana SpA | 98.73m | 4.28m | 36.83m | 323.00 | 8.12 | 0.7051 | 4.35 | 0.373 | 0.9549 | 0.9549 | 22.04 | 10.99 | 0.7586 | 2.86 | 2.94 | 366,204.30 | 3.29 | 2.72 | 5.40 | 4.72 | 24.44 | 28.12 | 4.33 | 3.78 | 1.41 | 5.13 | 0.5324 | -- | 21.66 | 11.34 | 43.52 | 21.76 | 13.33 | -- |
| AbL Diagnostics SA | 4.68m | 45.37k | 37.06m | 19.00 | 860.53 | 6.90 | 61.96 | 7.91 | 0.0034 | 0.0034 | 0.3483 | 0.42 | 0.3703 | -- | 1.42 | 295,411.60 | 0.3587 | 3.24 | 0.5884 | 4.43 | -- | -- | 0.9685 | 8.81 | 1.87 | -47.51 | 0.3389 | -- | -35.84 | 74.86 | -95.08 | -49.30 | -- | -- |
| Biosynex SA | 77.61m | -30.99m | 37.17m | 575.00 | -- | 0.3482 | -- | 0.4789 | -3.64 | -3.64 | 9.10 | 11.92 | 0.3704 | 1.16 | 7.34 | 161,700.90 | -14.18 | 14.90 | -17.51 | 19.41 | 52.84 | 51.92 | -38.30 | 14.61 | 1.03 | -28.00 | 0.3459 | -- | -52.70 | 24.40 | -337.76 | -- | -- | -- |
| Integrum AB | 7.57m | -187.00k | 39.52m | 36.00 | -- | 2.80 | 703.63 | 5.22 | -0.1244 | -0.1244 | 5.29 | 9.58 | 0.5706 | 0.5666 | 3.59 | 2,620,068.00 | -1.41 | -1.71 | -1.55 | -1.98 | 87.25 | 83.87 | -2.47 | -2.87 | 5.54 | -0.6636 | 0.0325 | -- | 40.19 | 35.91 | 124.92 | -- | 127.10 | -- |
| Modulight Oyj | 2.88m | -9.89m | 40.54m | 79.00 | -- | 0.9021 | -- | 14.08 | -0.2844 | -0.2844 | 0.0836 | 1.22 | 0.0516 | -0.3111 | 1.94 | 49,271.43 | -17.72 | -8.39 | -18.97 | -9.10 | 123.49 | 114.69 | -343.58 | -56.81 | 4.50 | -- | 0.0965 | -- | -12.48 | -8.20 | -38.69 | -- | 63.60 | -- |
| Tissue Regenix Group PLC | 23.78m | -823.31k | 42.73m | 76.00 | -- | 1.72 | 1,503.89 | 1.80 | -0.0117 | -0.0117 | 0.337 | 0.3146 | 0.7061 | 1.33 | 6.41 | 312,857.40 | -2.17 | -13.45 | -2.43 | -14.78 | 49.48 | 45.90 | -3.08 | -28.80 | 1.47 | 0.3716 | 0.263 | -- | 20.50 | 13.75 | 36.44 | -- | 9.78 | -- |
| Medicalgorithmics SA | 7.58m | -1.19m | 44.29m | 120.00 | -- | 2.74 | -- | 5.84 | -0.6131 | -0.6131 | 3.90 | 8.91 | 0.3263 | 4.13 | 9.12 | 323,541.70 | -5.13 | -0.9441 | -5.91 | -1.18 | -7.04 | 2.59 | -15.72 | -2.19 | 2.22 | -10.16 | 0.0451 | 0.00 | -31.28 | -26.39 | -102.27 | -- | -18.81 | -- |
| Bioretec Oy | 3.40m | -2.95m | 44.41m | 43.00 | -- | 8.65 | -- | 13.05 | -0.1752 | -0.1752 | 0.2024 | 0.318 | 0.4104 | 1.23 | 3.75 | 110,166.80 | -35.54 | -66.83 | -40.92 | -97.19 | 69.97 | 70.97 | -86.61 | -133.49 | 4.04 | -- | 0.0696 | -- | 32.78 | 19.77 | -54.02 | -- | -- | -- |
| Gentian Diagnostics ASA | 10.42m | -143.04k | 50.00m | 58.00 | -- | 4.21 | 96.81 | 4.80 | -0.1369 | -0.1369 | 9.43 | 10.20 | 0.7756 | 1.71 | 6.79 | 2,522,379.00 | -1.07 | -10.76 | -1.21 | -11.86 | 51.06 | 41.46 | -1.37 | -26.99 | 4.83 | -- | 0.047 | -- | 32.98 | 27.63 | 54.92 | -- | -4.92 | -- |
| OssDsign AB | 9.15m | -8.43m | 50.33m | 27.00 | -- | 2.91 | -- | 5.50 | -1.40 | -1.40 | 1.43 | 2.30 | 0.4311 | 2.50 | 6.80 | 2,572,083.00 | -39.74 | -37.92 | -43.39 | -43.56 | 83.94 | 68.10 | -92.18 | -203.06 | 5.92 | -21.65 | 0.0114 | -- | 96.84 | 53.26 | -31.30 | -- | -56.16 | -- |
Data as of Sep 30 2024. Currency figures normalised to Tissue Regenix Group PLC's reporting currency: UK Pound GBX
48.47%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Harwood Capital LLPas of 29 Feb 2024 | 10.62m | 14.87% |
| Lombard Odier Asset Management (Europe) Ltd.as of 18 Jun 2024 | 8.72m | 12.22% |
| UBS Asset Management (UK) Ltd.as of 01 Jul 2024 | 4.84m | 6.78% |
| Janus Henderson Investors UK Ltd.as of 01 Jul 2024 | 3.66m | 5.12% |
| Link Fund Solutions Ltd.as of 30 Jun 2019 | 2.34m | 3.28% |
| Hargreaves Lansdown Asset Management Ltd.as of 01 Jul 2024 | 2.27m | 3.18% |
| IG Markets Ltd.as of 01 Jul 2024 | 868.00k | 1.22% |
| Close Asset Management Ltd.as of 01 Jul 2024 | 475.00k | 0.67% |
| HSBC Global Asset Management (UK) Ltd.as of 01 Jul 2024 | 422.00k | 0.59% |
| J. M. Finn & Co. Ltd.as of 01 Jul 2024 | 390.00k | 0.55% |
More ▼
Data from 31 Mar 2023 - 01 Aug 2024Source: FactSet Research Systems Inc.
